TAF
AGN

Tredje AP-fonden’s Allergan plc AGN Stock Holding History

Tredje AP-fonden’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39,611
Closed -$7.01M – 254
2020
Q1 		$7.01M Buy
39,611
+3,940
+11% +$742K 0.36% 64
2019
Q4 		$6.82M Sell
35,671
-3,648
-9% -$658K 0.35% 68
2019
Q3 		$6.62M Sell
39,319
-7,658
-16% -$1.25M 0.32% 70
2019
Q2 		$7.87M Sell
46,977
-405
-0.9% -$56.1K 0.38% 61
2019
Q1 		$6.94M Buy
47,382
+1,395
+3% +$202K 0.36% 67
2018
Q4 		$6.15M Sell
45,987
-12,219
-21% -$2M 0.37% 63
2018
Q3 		$11.1M Sell
58,206
-22,743
-28% -$4.18M 0.53% 43
2018
Q2 		$13.5M Buy
80,949
+16,775
+26% +$2.69M 0.47% 57
2018
Q1 		$10.8M Buy
64,174
+580
+0.9% +$97.3K 0.38% 60
2017
Q4 		$10.4M Sell
63,594
-6
-0% -$1.08K 0.35% 64
2017
Q3 		$13M Sell
63,600
-341
-0.5% -$79.3K 0.46% 49
2017
Q2 		$15.5M Sell
63,941
-4,600
-7% -$1.08M 0.58% 35
2017
Q1 		$16.4M Buy
68,541
+625
+0.9% +$146K 0.65% 25
2016
Q4 		$14.3M Sell
67,916
-1,066
-2% -$221K 0.6% 38
2016
Q3 		$15.9M Sell
68,982
-1,918
-3% -$469K 0.72% 26
2016
Q2 		$16.4M Sell
70,900
-1,863
-3% -$430K 0.73% 29
2016
Q1 		$16.2M Buy
72,763
+15,692
+27% +$4.49M 0.74% 29
2015
Q4 		$17.8M Buy
57,071
+31,728
+125% +$9.45M 1.14% 15
2015
Q3 		$6.89M Sell
25,343
-894
-3% -$275K 0.67% 36
2015
Q2 		$7.96M Buy
+26,237
New +$7.83M 0.64% 37

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Tredje AP-fonden's AGN Position: Q2 2020 in Review

Tredje AP-fonden sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 39,611 shares — an estimated $7.01M sold.

Tredje AP-fonden first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $17.8M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tredje AP-fonden reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tredje AP-fonden sold 39,611 Allergan plc shares in Q2 2020, an estimated $7.01M.
  • Tredje AP-fonden first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Tredje AP-fonden's Allergan plc position peaked at $17.8M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tredje AP-fonden's 13F filing for Q2 2020, filed 11 Aug 2020.